首页 > 最新文献

Medical Journal of Malaysia最新文献

英文 中文
Quality control of Actinium-225 radiopharmaceuticals: Current challenges and solutions in Malaysia. 锕-225放射性药物的质量控制:马来西亚当前的挑战和解决办法。
Q3 Medicine Pub Date : 2024-11-01
Z Ashhar, M F Fadzil, M A Said, M Mujahid, S Suppiah

Development of Prostate Specific Membrane Antigen (PSMA)-targeted radiopharmaceuticals for theranostics has changed the treatment landscape for patients with metastatic castration-resistant prostate cancer (mCRPC). The emerging use of [225Ac]Ac-PSMA-RLT has been effective and safe for the treatment of mCRPC. Nevertheless, challenges with the nuclear recoil of [225Ac]Actinium radionuclides, which may release the daughter radionuclide from the radiopharmaceutical and lead to unnecessary irradiation of other organs, poses threats such as organ dysfunction. Therefore, this short communication aims to highlight the current situation in Malaysia and explain the solutions by using a risk-based approach analysis for the inhouse preparation.

前列腺特异性膜抗原(PSMA)靶向放射药物的发展改变了转移性去势抵抗性前列腺癌(mCRPC)患者的治疗前景。[225Ac]Ac-PSMA-RLT治疗mCRPC有效且安全。然而,[225Ac]锕放射性核素的核后坐力带来的挑战,可能会从放射性药物中释放出子放射性核素,并导致对其他器官的不必要照射,从而造成器官功能障碍等威胁。因此,这篇简短的沟通旨在强调马来西亚的现状,并通过使用基于风险的方法分析内部准备来解释解决方案。
{"title":"Quality control of Actinium-225 radiopharmaceuticals: Current challenges and solutions in Malaysia.","authors":"Z Ashhar, M F Fadzil, M A Said, M Mujahid, S Suppiah","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Development of Prostate Specific Membrane Antigen (PSMA)-targeted radiopharmaceuticals for theranostics has changed the treatment landscape for patients with metastatic castration-resistant prostate cancer (mCRPC). The emerging use of [<sup>225</sup>Ac]Ac-PSMA-RLT has been effective and safe for the treatment of mCRPC. Nevertheless, challenges with the nuclear recoil of [<sup>225</sup>Ac]Actinium radionuclides, which may release the daughter radionuclide from the radiopharmaceutical and lead to unnecessary irradiation of other organs, poses threats such as organ dysfunction. Therefore, this short communication aims to highlight the current situation in Malaysia and explain the solutions by using a risk-based approach analysis for the inhouse preparation.</p>","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 6","pages":"794-799"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organisms causing community-acquired bloodstream infection in medical department: A single centre retrospective observational study. 引起内科社区获得性血流感染的病原体:单中心回顾性观察研究。
Q3 Medicine Pub Date : 2024-09-01
R Suganthini, T Suvintheran, Z A Nor Zanariah

Introduction: Community acquired bloodstream infection (CA-BSI) is positive blood culture obtained within 48 hours of hospital admission. Bloodstream infections need to be treated with antibiotics. Inappropriate choice of antibiotics will lead to antimicrobial resistance. This is an observational retrospective study to look at the antimicrobial resistance of organisms causing bloodstream infections in patients admitted to the medical wards in our centre. The aim of the study is to determine the appropriate choice of empirical antibiotics for suspected CA-BSI in our hospital.

Materials and methods: All patients admitted to medical wards with blood stream infection during the period January 2021 to June 2021 were enrolled. Identification of organisms and antimicrobial susceptibility testing were obtained. Information regarding the severity of the bacteremia was collected by assessing if the patient needed inotropes, mechanical ventilation or renal replacement therapy. Data on comorbidities which were the presence of end-stage renal failure, diabetic mellitus and immunosuppression were collected.

Results: Total of 269 cases were screened. Out of these 104 communities acquired cases were included. The pathogens frequently isolated were gram negative organisms most commonly Escherichia coli (43%) and Klebsiella species (30%). Staphylococcus aureus accounts for the majority of gram-positive organisms. Only two out of 20 Staphylococcus aureus were methicillin resistant. Bulkholderia pseudomallei accounts for 7.8% cases. All Burkholderia pseudomallei isolates were sensitive to cotrimoxazole. Escherichia coli (46%) isolates demonstrated a higher resistance pattern to Augmentin compared to klebsiella species (17.4%). The overall mortality rate was 22%, with higher rates for those critically ill (39%). Patients with Enterobacteriaceae infection showed no difference in outcome between the groups of patients according to sensitivity to Augmentin and cefotaxime. These groups of patients who were critically ill did not demonstrate any significant difference in terms of resistance pattern to Augmentin (p = 0.3) and cefotaxime (p = 0.7). Patients who are aged 65 or older have a significantly more resistant pattern to Augmentin and cefotaxime.

Conclusion: Antibiogram serves as a guide for clinicians to choose appropriate choices of antibiotics based on local data. Empirical antibiotics of choice for patients with sepsis should be narrow-spectrum beta lactam/beta lactamase inhibitors. Broad spectrum beta lactam/beta lactamase inhibitors such as piperacillin tazobactam should be reserved for patients who are critically ill and elderly patients over 65 years. The antibiotics should be deescalated once the organisms and sensitivity of the antibiotics are known.

导言:社区获得性血流感染(CA-BSI)是指入院 48 小时内血液培养呈阳性。血流感染需要使用抗生素治疗。抗生素选择不当会导致抗菌药耐药性。这是一项观察性回顾研究,旨在了解本中心内科病房住院病人中引起血流感染的微生物对抗生素的耐药性。研究的目的是确定本医院在治疗疑似 CA-BSI 时经验性抗生素的适当选择:研究对象为 2021 年 1 月至 2021 年 6 月期间内科病房收治的所有血流感染患者。进行微生物鉴定和抗菌药敏感性测试。通过评估患者是否需要肌注、机械通气或肾脏替代治疗,收集有关菌血症严重程度的信息。此外,还收集了合并症数据,包括终末期肾衰竭、糖尿病和免疫抑制:结果:共筛查出 269 个病例。结果:共筛查出 269 例病例,其中 104 例为社区获得性病例。经常分离到的病原体是革兰氏阴性菌,最常见的是大肠埃希菌(43%)和克雷伯菌(30%)。金黄色葡萄球菌占革兰氏阳性菌的大多数。20 个金黄色葡萄球菌中只有两个对甲氧西林有抗药性。假马来球菌占 7.8%。所有分离到的假马来球菌都对复方新诺明敏感。与克雷伯氏菌(17.4%)相比,大肠埃希菌(46%)分离株对奥格门汀的耐药性更高。总死亡率为 22%,重症患者的死亡率更高(39%)。肠杆菌科细菌感染患者对奥格门汀和头孢他啶的敏感性显示,各组患者的预后没有差异。这两组重症患者对奥格门汀(P = 0.3)和头孢他啶(P = 0.7)的耐药性模式也无明显差异。65岁或以上的患者对Augmentin和头孢他啶的耐药模式明显更多:抗生素图谱是临床医生根据当地数据选择适当抗生素的指南。败血症患者的经验性抗生素应选择窄谱β-内酰胺/β-内酰胺酶抑制剂。广谱β-内酰胺/β-内酰胺酶抑制剂(如哌拉西林他唑巴坦)应保留给重症患者和 65 岁以上的老年患者。一旦知道病原体和对抗生素的敏感性,就应降低抗生素的等级。
{"title":"Organisms causing community-acquired bloodstream infection in medical department: A single centre retrospective observational study.","authors":"R Suganthini, T Suvintheran, Z A Nor Zanariah","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Community acquired bloodstream infection (CA-BSI) is positive blood culture obtained within 48 hours of hospital admission. Bloodstream infections need to be treated with antibiotics. Inappropriate choice of antibiotics will lead to antimicrobial resistance. This is an observational retrospective study to look at the antimicrobial resistance of organisms causing bloodstream infections in patients admitted to the medical wards in our centre. The aim of the study is to determine the appropriate choice of empirical antibiotics for suspected CA-BSI in our hospital.</p><p><strong>Materials and methods: </strong>All patients admitted to medical wards with blood stream infection during the period January 2021 to June 2021 were enrolled. Identification of organisms and antimicrobial susceptibility testing were obtained. Information regarding the severity of the bacteremia was collected by assessing if the patient needed inotropes, mechanical ventilation or renal replacement therapy. Data on comorbidities which were the presence of end-stage renal failure, diabetic mellitus and immunosuppression were collected.</p><p><strong>Results: </strong>Total of 269 cases were screened. Out of these 104 communities acquired cases were included. The pathogens frequently isolated were gram negative organisms most commonly Escherichia coli (43%) and Klebsiella species (30%). Staphylococcus aureus accounts for the majority of gram-positive organisms. Only two out of 20 Staphylococcus aureus were methicillin resistant. Bulkholderia pseudomallei accounts for 7.8% cases. All Burkholderia pseudomallei isolates were sensitive to cotrimoxazole. Escherichia coli (46%) isolates demonstrated a higher resistance pattern to Augmentin compared to klebsiella species (17.4%). The overall mortality rate was 22%, with higher rates for those critically ill (39%). Patients with Enterobacteriaceae infection showed no difference in outcome between the groups of patients according to sensitivity to Augmentin and cefotaxime. These groups of patients who were critically ill did not demonstrate any significant difference in terms of resistance pattern to Augmentin (p = 0.3) and cefotaxime (p = 0.7). Patients who are aged 65 or older have a significantly more resistant pattern to Augmentin and cefotaxime.</p><p><strong>Conclusion: </strong>Antibiogram serves as a guide for clinicians to choose appropriate choices of antibiotics based on local data. Empirical antibiotics of choice for patients with sepsis should be narrow-spectrum beta lactam/beta lactamase inhibitors. Broad spectrum beta lactam/beta lactamase inhibitors such as piperacillin tazobactam should be reserved for patients who are critically ill and elderly patients over 65 years. The antibiotics should be deescalated once the organisms and sensitivity of the antibiotics are known.</p>","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"569-574"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary tuberculosis diagnostic test using fluorescence immunoassay-based interferon gamma release assay with IchromaTM IGRA-TB. 使用基于荧光免疫测定的 IchromaTM IGRA-TB γ 干扰素释放测定法进行肺结核诊断检测。
Q3 Medicine Pub Date : 2024-09-01
B Bermawi, D W Kurniasari, A Imaniar, N Hidayatih, D A Lisnawati, I F Rofananda, P Prihatini

Introduction: Tuberculosis (TB) is a serious global health problem in Indonesia, which is the country with the secondhighest TB burden after India. Accuracy in TB diagnosis is the key to effective treatment and decreased transmission rate. One of the latest diagnostic methods is interferon gamma release assay (IGRA), which measures the interferon-γ release associated with Mycobacterium tuberculosis (MTB) infection. This study aims to determine the diagnostic value of IGRA-TB using IchromaTM IGRA-TB diagnostic kit (sensitivity, specificity, positive predictive value [PPV], and negative predictive value [NPV]), compared to Ziehl-Neelsen (AFB) staining, nucleic acid amplificationbased test (Xpert-MTB) and chest-X Ray as the gold standard in TB diagnosis.

Materials and methods: A cross-sectional observational study design was used. Patients were recruited through purposive sampling from pulmonology outpatient clinic and inpatient ward at Jemursari Islamic Hospital (RSI Jemursari), Surabaya from July 2023 to December 2023. All enrolled patients should have been previously tested positive or negative for pulmonary TB using AFB staining, Xpert MTB and chest x-ray. Blood samples of the patients were collected and processed using the IchromaTM IGRA-TB diagnostic kit. The results were then compared with gold standard methods for calculating the IGRA-TB diagnostic value.

Results: A total of 56 adult patients were enrolled in this study. The sensitivity, specificity, PPV, NPV and accuracy rate of IGRA-TB using IchromaTM IGRA-TB diagnostic kit were 80.56%, 85%, 90.62%, 70.83% and 82.14%, respectively.

Conclusion: IchromaTM IGRA-TB showed reasonably high diagnostic sensitivity and specificity, indicating that this method can be further utilised as a diagnostic and screening tool for pulmonary TB.

导言:在印度尼西亚,结核病是一个严重的全球健康问题,该国的结核病负担仅次于印度。结核病诊断的准确性是有效治疗和降低传播率的关键。干扰素γ释放测定(IGRA)是最新的诊断方法之一,它可以测量与结核分枝杆菌(MTB)感染相关的干扰素γ释放。本研究旨在确定使用 IchromaTM IGRA-TB 诊断试剂盒的 IGRA-TB 的诊断价值(灵敏度、特异性、阳性预测值 [PPV] 和阴性预测值 [NPV]),并与作为肺结核诊断金标准的齐氏-奈尔森(AFB)染色法、基于核酸扩增的检测法(Xpert-MTB)和胸部 X 线片进行比较:采用横断面观察研究设计。患者于 2023 年 7 月至 2023 年 12 月期间通过有目的的抽样从泗水 Jemursari 伊斯兰医院(RSI Jemursari)的肺科门诊和住院病房招募。所有入选患者均应曾通过AFB染色、Xpert MTB和胸部X光检查发现肺结核呈阳性或阴性。患者的血样由 IchromaTM IGRA-TB 诊断试剂盒采集和处理。然后将结果与计算 IGRA-TB 诊断值的金标准方法进行比较:结果:本研究共纳入 56 名成年患者。使用 IchromaTM IGRA-TB 诊断试剂盒检测 IGRA-TB 的敏感性、特异性、PPV、NPV 和准确率分别为 80.56%、85%、90.62%、70.83% 和 82.14%:IchromaTM IGRA-TB 诊断试剂盒显示出相当高的诊断灵敏度和特异性,表明该方法可进一步用作肺结核的诊断和筛查工具。
{"title":"Pulmonary tuberculosis diagnostic test using fluorescence immunoassay-based interferon gamma release assay with IchromaTM IGRA-TB.","authors":"B Bermawi, D W Kurniasari, A Imaniar, N Hidayatih, D A Lisnawati, I F Rofananda, P Prihatini","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Tuberculosis (TB) is a serious global health problem in Indonesia, which is the country with the secondhighest TB burden after India. Accuracy in TB diagnosis is the key to effective treatment and decreased transmission rate. One of the latest diagnostic methods is interferon gamma release assay (IGRA), which measures the interferon-γ release associated with Mycobacterium tuberculosis (MTB) infection. This study aims to determine the diagnostic value of IGRA-TB using IchromaTM IGRA-TB diagnostic kit (sensitivity, specificity, positive predictive value [PPV], and negative predictive value [NPV]), compared to Ziehl-Neelsen (AFB) staining, nucleic acid amplificationbased test (Xpert-MTB) and chest-X Ray as the gold standard in TB diagnosis.</p><p><strong>Materials and methods: </strong>A cross-sectional observational study design was used. Patients were recruited through purposive sampling from pulmonology outpatient clinic and inpatient ward at Jemursari Islamic Hospital (RSI Jemursari), Surabaya from July 2023 to December 2023. All enrolled patients should have been previously tested positive or negative for pulmonary TB using AFB staining, Xpert MTB and chest x-ray. Blood samples of the patients were collected and processed using the IchromaTM IGRA-TB diagnostic kit. The results were then compared with gold standard methods for calculating the IGRA-TB diagnostic value.</p><p><strong>Results: </strong>A total of 56 adult patients were enrolled in this study. The sensitivity, specificity, PPV, NPV and accuracy rate of IGRA-TB using IchromaTM IGRA-TB diagnostic kit were 80.56%, 85%, 90.62%, 70.83% and 82.14%, respectively.</p><p><strong>Conclusion: </strong>IchromaTM IGRA-TB showed reasonably high diagnostic sensitivity and specificity, indicating that this method can be further utilised as a diagnostic and screening tool for pulmonary TB.</p>","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"604-607"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse event following immunisation of adsorbed-inactivated Coronavac (Sinovac) and ChAdOx1 nCOV-19 (Astra Zeneca) of COVID-19 vaccines. COVID-19吸附灭活疫苗Coronavac(Sinovac)和COVID-19吸附灭活疫苗ChAdOx1 nCOV-19(Astra Zeneca)免疫后的不良事件。
Q3 Medicine Pub Date : 2024-09-01
A Simatupang, Y R M B Sitompul, B Simanungkalit, K Kurniyanto, L N Achmad, F Sitompul, S M Mahmud, E Suarthana

Introduction: Countries around the world organised mass vaccinations using various types of vaccines against COVID-19, like inactivated viruses and mRNA. The study aimed to look at adverse events following immunisation (AEFI) of Coronavac® (SIN) and ChAdOx1 nCOV-19 ® (AZ) COVID-19 vaccines in Indonesia.

Materials and methods: Subjects who received SIN or AZ vaccines were sent questionnaires twice: after they received the first and the second doses of vaccine, respectively. AEFI data on the first- and second-day post-vaccination were collected and analyzed descriptively.

Results: A total of 1547 people vaccinated with SIN vaccine, 529 (33.3%) responded to the first-dose and 239 (47%) to the second-dose questionnaires, whereas 936 people vaccinated with AZ vaccine, 483 (51.6%) answered the firstdose and 123 (25%) to the second-dose questionnaires. Some important AEFIs on the first- and second-day post receiving SIN vs. AZ vaccination were as follows: fever 4% vs 59%; pain at the injection site 27% vs 87%; redness and swelling at the injection site 4% vs 18%; nausea 5% vs 30%; diarrhea 1.8% vs 5.7%, respectively.

Conclusion: SIN seemed to have fewer AEFIs than AZ. Apart from different vaccine materials and excipients, the gap in AEFIs between SIN and AZ could be caused by the distinct population where AZ recipients were more exposed to COVID-19.

导言:世界各国使用各种类型的 COVID-19 疫苗(如灭活病毒和 mRNA)组织了大规模疫苗接种。本研究旨在调查印度尼西亚接种 Coronavac® (SIN) 和 ChAdOx1 nCOV-19 ® (AZ) COVID-19 疫苗后发生的不良事件 (AEFI):接受 SIN 或 AZ 疫苗接种的受试者分别在接种第一剂和第二剂疫苗后接受了两次问卷调查。收集接种后第一天和第二天的 AEFI 数据并进行描述性分析:共有 1547 人接种了 SIN 疫苗,其中 529 人(33.3%)回答了第一剂问卷,239 人(47%)回答了第二剂问卷;共有 936 人接种了 AZ 疫苗,其中 483 人(51.6%)回答了第一剂问卷,123 人(25%)回答了第二剂问卷。接种 SIN 与 AZ 疫苗后第一天和第二天的一些重要 AEFI 如下:发烧 4% 对 59%;注射部位疼痛 27% 对 87%;注射部位红肿 4% 对 18%;恶心 5% 对 30%;腹泻 1.8% 对 5.7%:结论:SIN 的 AEFI 似乎比 AZ 少。除了疫苗材料和辅料不同外,SIN 和 AZ 在 AEFIs 方面的差距可能是由于人群不同造成的,AZ 受试者接触 COVID-19 的机会更多。
{"title":"Adverse event following immunisation of adsorbed-inactivated Coronavac (Sinovac) and ChAdOx1 nCOV-19 (Astra Zeneca) of COVID-19 vaccines.","authors":"A Simatupang, Y R M B Sitompul, B Simanungkalit, K Kurniyanto, L N Achmad, F Sitompul, S M Mahmud, E Suarthana","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Countries around the world organised mass vaccinations using various types of vaccines against COVID-19, like inactivated viruses and mRNA. The study aimed to look at adverse events following immunisation (AEFI) of Coronavac® (SIN) and ChAdOx1 nCOV-19 ® (AZ) COVID-19 vaccines in Indonesia.</p><p><strong>Materials and methods: </strong>Subjects who received SIN or AZ vaccines were sent questionnaires twice: after they received the first and the second doses of vaccine, respectively. AEFI data on the first- and second-day post-vaccination were collected and analyzed descriptively.</p><p><strong>Results: </strong>A total of 1547 people vaccinated with SIN vaccine, 529 (33.3%) responded to the first-dose and 239 (47%) to the second-dose questionnaires, whereas 936 people vaccinated with AZ vaccine, 483 (51.6%) answered the firstdose and 123 (25%) to the second-dose questionnaires. Some important AEFIs on the first- and second-day post receiving SIN vs. AZ vaccination were as follows: fever 4% vs 59%; pain at the injection site 27% vs 87%; redness and swelling at the injection site 4% vs 18%; nausea 5% vs 30%; diarrhea 1.8% vs 5.7%, respectively.</p><p><strong>Conclusion: </strong>SIN seemed to have fewer AEFIs than AZ. Apart from different vaccine materials and excipients, the gap in AEFIs between SIN and AZ could be caused by the distinct population where AZ recipients were more exposed to COVID-19.</p>","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"507-511"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world efficacy and safety of intravenous ferric carboxymaltose for the management of iron deficiency anaemia in Malaysia: A single centre cohort study. 在马来西亚,静脉注射羧甲基亚铁治疗缺铁性贫血的实际疗效和安全性:单中心队列研究。
Q3 Medicine Pub Date : 2024-09-01
H N B Kamarul
<p><strong>Introduction: </strong>Up to 24.2% Malaysians are estimated to be affected by anaemia. Iron deficiency is the most common nutritional deficiency leading to anaemia. Oral iron therapy may not be well tolerated or efficient. Ferric carboxymaltose (FCM), a non-dextran intravenous iron formulation, may be an appealing alternative for iron replacement therapy. This retrospective study aimed to investigate the efficacy and safety of intravenous FCM infusion for the management of iron deficiency anaemia in a single centre in Malaysia.</p><p><strong>Materials and methods: </strong>All patients who received at least one dose of 500 mg intravenous FCM infusion from January to December 2023 in Bukit Tinggi Medical Centre (BTMC) were identified from the electronic medical record database. Inclusion criteria were patients: (1) ≥ 14 years old and (2) with iron deficiency anaemia. The primary outcome was the mean change in haemoglobin level before treatment and 30 day after treatment. Secondary outcomes included reasons for intravenous FCM infusion, median dose, adverse drug reactions, mean change in haemoglobin levels for different subgroups and percentage of patients with normalised haemoglobin after treatment. The efficacy outcome was analysed using per-protocol analysis while the safety outcome used intention-to-treat analysis. Paired t-test was used to compare the mean difference between the haemoglobin measurements before and 30-day after treatment.</p><p><strong>Results: </strong>A total of 144 administrations were given to 141 patients requiring intravenous iron replacement therapy during the 1-year study period in BTMC. Intravenous FCM infusion was administered for the management of iron deficiency related to: (1) increased blood loss, including menorrhagia, haemorrhoids and GI-related surgery, (2) low iron intake, including poor nutrition and gastrointestinalrelated malabsorption and (3) haematological disorders, including autoimmune haemolytic anaemia, myelodysplastic syndrome, diffuse large B-cell lymphoma and idiopathic thrombocytopaenia purpura. The median dose of intravenous FCM infusion was 1000 mg. At 30 day post-infusion, the mean haemoglobin level increased significantly from 8.9 g/L to 11.6 g/L (p < 0.05), an increase of 2.68 g/L (95% CI: 2.45 - 2.90 g/L). No adverse drug reactions were reported. Subgroup analysis showed that patients with haematological disorders had significantly higher improvement in haemoglobin levels after intravenous iron infusion compared to those without. At 7-day, 14-day, 21-day post-infusion, 33% (33/99), 34% (34/99) and 36% (36/99) patients had a normalised haemoglobin level, respectively. The proportion of patients with a normalised haemoglobin level increased to 36% (36/99) and 42% (42/99) at 30-day and 90-day post-infusion.</p><p><strong>Conclusion: </strong>Within the limit of this single-centre retrospective study, intravenous FCM infusion was well tolerated and effective in increasing the haemoglo
导言:据估计,受贫血影响的马来西亚人高达 24.2%。缺铁是导致贫血最常见的营养缺乏症。口服铁剂治疗的耐受性和效率可能不佳。羧甲基铁(FCM)是一种非右旋糖酐静脉注射铁制剂,可能是铁替代疗法的一种有吸引力的选择。这项回顾性研究旨在调查马来西亚一家中心静脉输注羧甲基铁治疗缺铁性贫血的有效性和安全性:从电子病历数据库中筛选出 2023 年 1 月至 12 月期间在武吉丁宜医疗中心(BTMC)接受过至少一次 500 毫克 FCM 静脉注射的所有患者。纳入标准为患者(1) 年龄≥ 14 岁;(2) 患有缺铁性贫血。主要结果是治疗前和治疗后 30 天血红蛋白水平的平均变化。次要结果包括静脉输注 FCM 的原因、中位剂量、药物不良反应、不同亚组血红蛋白水平的平均变化以及治疗后血红蛋白恢复正常的患者百分比。疗效结果采用按方案分析法,安全性结果采用意向治疗分析法。采用配对 t 检验比较治疗前和治疗后 30 天血红蛋白测量值的平均差异:结果:在为期 1 年的研究期间,BTMC 共为 141 名需要静脉注射铁剂的患者注射了 144 次铁剂。静脉输注 FCM 的目的是治疗与以下原因有关的铁缺乏症:(1) 失血量增加,包括月经过多、痔疮和胃肠道相关手术;(2) 铁摄入量低,包括营养不良和胃肠道相关吸收不良;(3) 血液病,包括自身免疫性溶血性贫血、骨髓增生异常综合征、弥漫性大 B 细胞淋巴瘤和特发性血小板减少性紫癜。静脉输注 FCM 的中位剂量为 1000 毫克。输注后 30 天,平均血红蛋白水平从 8.9 克/升显著升至 11.6 克/升(P < 0.05),增加了 2.68 克/升(95% CI:2.45 - 2.90 克/升)。无药物不良反应报告。亚组分析显示,与无血液病的患者相比,有血液病的患者在静脉输注铁剂后血红蛋白水平的改善程度明显更高。输注后 7 天、14 天和 21 天,分别有 33% (33/99)、34% (34/99) 和 36% (36/99) 的患者血红蛋白水平恢复正常。输液后 30 天和 90 天,血红蛋白水平恢复正常的患者比例分别增至 36%(36/99)和 42%(42/99):在这项单中心回顾性研究的范围内,静脉输注 FCM 的耐受性良好,并能有效提高缺铁性贫血患者的血红蛋白水平。
{"title":"Real-world efficacy and safety of intravenous ferric carboxymaltose for the management of iron deficiency anaemia in Malaysia: A single centre cohort study.","authors":"H N B Kamarul","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Up to 24.2% Malaysians are estimated to be affected by anaemia. Iron deficiency is the most common nutritional deficiency leading to anaemia. Oral iron therapy may not be well tolerated or efficient. Ferric carboxymaltose (FCM), a non-dextran intravenous iron formulation, may be an appealing alternative for iron replacement therapy. This retrospective study aimed to investigate the efficacy and safety of intravenous FCM infusion for the management of iron deficiency anaemia in a single centre in Malaysia.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;All patients who received at least one dose of 500 mg intravenous FCM infusion from January to December 2023 in Bukit Tinggi Medical Centre (BTMC) were identified from the electronic medical record database. Inclusion criteria were patients: (1) ≥ 14 years old and (2) with iron deficiency anaemia. The primary outcome was the mean change in haemoglobin level before treatment and 30 day after treatment. Secondary outcomes included reasons for intravenous FCM infusion, median dose, adverse drug reactions, mean change in haemoglobin levels for different subgroups and percentage of patients with normalised haemoglobin after treatment. The efficacy outcome was analysed using per-protocol analysis while the safety outcome used intention-to-treat analysis. Paired t-test was used to compare the mean difference between the haemoglobin measurements before and 30-day after treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 144 administrations were given to 141 patients requiring intravenous iron replacement therapy during the 1-year study period in BTMC. Intravenous FCM infusion was administered for the management of iron deficiency related to: (1) increased blood loss, including menorrhagia, haemorrhoids and GI-related surgery, (2) low iron intake, including poor nutrition and gastrointestinalrelated malabsorption and (3) haematological disorders, including autoimmune haemolytic anaemia, myelodysplastic syndrome, diffuse large B-cell lymphoma and idiopathic thrombocytopaenia purpura. The median dose of intravenous FCM infusion was 1000 mg. At 30 day post-infusion, the mean haemoglobin level increased significantly from 8.9 g/L to 11.6 g/L (p &lt; 0.05), an increase of 2.68 g/L (95% CI: 2.45 - 2.90 g/L). No adverse drug reactions were reported. Subgroup analysis showed that patients with haematological disorders had significantly higher improvement in haemoglobin levels after intravenous iron infusion compared to those without. At 7-day, 14-day, 21-day post-infusion, 33% (33/99), 34% (34/99) and 36% (36/99) patients had a normalised haemoglobin level, respectively. The proportion of patients with a normalised haemoglobin level increased to 36% (36/99) and 42% (42/99) at 30-day and 90-day post-infusion.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Within the limit of this single-centre retrospective study, intravenous FCM infusion was well tolerated and effective in increasing the haemoglo","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"517-524"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142356001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of outcomes in epithelial ovarian cancer, fallopian tube cancer and primary peritoneal serous carcinoma between a multidisciplinary and a single-speciality centre. 多学科中心与单一专科中心对上皮性卵巢癌、输卵管癌和原发性腹膜浆液性癌治疗效果的比较。
Q3 Medicine Pub Date : 2024-09-01
M N Senin, C M Yong, J Omar, W N A Wan Fadzil Adlan, B C Lim
<p><strong>Introduction: </strong>Epithelial ovarian cancer (EOC) is the fourth most common malignancy among Malaysian women. This study aims to evaluate the outcomes of EOC, fallopian tube cancer and primary peritoneal serous carcinoma (PPSC) between a centre managed by both clinical oncologists and gynaecologic oncologists, Institut Kanser Negara (IKN) and a centre managed solely by gynaecologic oncologists, Hospital Ampang (HA).</p><p><strong>Materials and methods: </strong>This retrospective cohort study involved data review of all the newly diagnosed patients with EOC, fallopian tube cancer and PPSC who received treatment in IKN and HA from January 2015 to December 2019, with follow-up continuing until December 2022. The primary outcome is overall survival (OS) and the secondary outcome is progression free survival (PFS) rates; estimated using the Kaplan-Meier method and compared using the logrank test. Another secondary outcome is to determine the prognostic factors affecting the OS of patients from these two cohorts using Cox regression analysis.</p><p><strong>Results: </strong>A total of 256 patients from both centres were recruited (106 and 150 patients from IKN and HA respectively) and at the time of diagnosis, more than half of the patients were diagnosed with advanced stage disease (67.5% and 62% from IKN and HA respectively). The median OS for patients with EOC was significantly longer for HA compared to IKN (69 months vs 39 months, p < 0.042). There was no significant difference in the median PFS for both centres. Furthermore, when the comparison was made based on the disease staging, there was no difference in the median OS and median PFS. Multivariate analysis identified that patients aged between 41 and 60 years (Hazard ratio [HR]: 2.83; 95% CI: 1.11, 7.25, p = 0.030), patients with medical illness (HR 1.51; 95% CI: 1.04, 2.21, p = 0.033), patients with advanced-stage disease (HR: 3.63; 95% CI: 2.20, 6.00, p < 0.001) and patients with ECOG ≥ 1 (HR: 2.00; 95%CI: 1.38, 2.91, p < 0.001) as independent risk factors for adverse outcome. Meanwhile, optimal surgery is found to be a protective factor (HR 0.60; 95% CI: 0.41, 0.89, p = 0.011). Patients with optimal surgery had reduced the risk of adverse outcome.</p><p><strong>Conclusion: </strong>Our findings confirmed that the median OS was significantly longer for patients with EOC in HA compared to IKN. However, there was no significant difference in the median OS based on the disease staging; therefore, we could not establish the non-inferiority outcome between the two centres. Furthermore, there was no significant difference in median PFS for both centres. This could be due to small sample size to be able to detect any difference. In addition, it could also be contributed by the different treatment options available and unequal volume of patients treated in both centres. Thus, further study with larger sample size and longer time period is needed to provide better guidance and treatm
简介上皮性卵巢癌(EOC)是马来西亚妇女中第四大最常见的恶性肿瘤。本研究旨在评估由临床肿瘤学家和妇科肿瘤学家共同管理的中心(Institut Kanser Negara,简称IKN)与仅由妇科肿瘤学家管理的中心(Hospital Ampang,简称HA)之间EOC、输卵管癌和原发性腹膜浆液性癌(Primary Peritoneal Serous carcinoma,简称PPSC)的治疗效果:这项回顾性队列研究涉及2015年1月至2019年12月期间在IKN和HA接受治疗的所有新确诊的EOC、输卵管癌和PPSC患者的数据回顾,随访持续至2022年12月。主要结果是总生存期(OS),次要结果是无进展生存期(PFS)率;采用卡普兰-梅耶法估算,并用对数秩检验进行比较。另一个次要结果是使用 Cox 回归分析确定影响这两个队列患者 OS 的预后因素:两个中心共招募了256名患者(IKN和HA分别招募了106名和150名患者),在确诊时,超过半数的患者被诊断为晚期疾病(IKN和HA分别为67.5%和62%)。与IKN相比,HA的EOC患者中位OS明显更长(69个月 vs 39个月,P < 0.042)。两个中心的中位生存期没有明显差异。此外,如果根据疾病分期进行比较,中位OS和中位PFS也没有差异。多变量分析发现,年龄在 41 至 60 岁之间的患者(危险比 [HR]:2.83;95% CI:1.11, 7.25,P = 0.030)、患有内科疾病的患者(HR:1.51;95% CI:1.04, 2.21,P = 0.033)、疾病晚期患者(HR:3.63;95% CI:2.20,6.00,P<0.001)和 ECOG ≥ 1 患者(HR:2.00;95%CI:1.38,2.91,P<0.001)为不良预后的独立危险因素。同时,最佳手术是一个保护因素(HR 0.60; 95%CI: 0.41, 0.89, p = 0.011)。结论:我们的研究结果表明,中位OS为0.1,而OS为0.2:我们的研究结果证实,与IKN相比,HA的EOC患者的中位OS明显更长。然而,根据疾病分期,中位OS无明显差异;因此,我们无法确定两家中心的非劣效性结果。此外,两个中心的中位生存期也没有明显差异。这可能是由于样本量较小,无法检测到任何差异。此外,这也可能是由于两个中心的治疗方案不同,以及治疗的患者数量不等。因此,有必要进行样本量更大、时间更长的进一步研究,以便为患者提供更好的指导和治疗方法。
{"title":"Comparison of outcomes in epithelial ovarian cancer, fallopian tube cancer and primary peritoneal serous carcinoma between a multidisciplinary and a single-speciality centre.","authors":"M N Senin, C M Yong, J Omar, W N A Wan Fadzil Adlan, B C Lim","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Epithelial ovarian cancer (EOC) is the fourth most common malignancy among Malaysian women. This study aims to evaluate the outcomes of EOC, fallopian tube cancer and primary peritoneal serous carcinoma (PPSC) between a centre managed by both clinical oncologists and gynaecologic oncologists, Institut Kanser Negara (IKN) and a centre managed solely by gynaecologic oncologists, Hospital Ampang (HA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;This retrospective cohort study involved data review of all the newly diagnosed patients with EOC, fallopian tube cancer and PPSC who received treatment in IKN and HA from January 2015 to December 2019, with follow-up continuing until December 2022. The primary outcome is overall survival (OS) and the secondary outcome is progression free survival (PFS) rates; estimated using the Kaplan-Meier method and compared using the logrank test. Another secondary outcome is to determine the prognostic factors affecting the OS of patients from these two cohorts using Cox regression analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 256 patients from both centres were recruited (106 and 150 patients from IKN and HA respectively) and at the time of diagnosis, more than half of the patients were diagnosed with advanced stage disease (67.5% and 62% from IKN and HA respectively). The median OS for patients with EOC was significantly longer for HA compared to IKN (69 months vs 39 months, p &lt; 0.042). There was no significant difference in the median PFS for both centres. Furthermore, when the comparison was made based on the disease staging, there was no difference in the median OS and median PFS. Multivariate analysis identified that patients aged between 41 and 60 years (Hazard ratio [HR]: 2.83; 95% CI: 1.11, 7.25, p = 0.030), patients with medical illness (HR 1.51; 95% CI: 1.04, 2.21, p = 0.033), patients with advanced-stage disease (HR: 3.63; 95% CI: 2.20, 6.00, p &lt; 0.001) and patients with ECOG ≥ 1 (HR: 2.00; 95%CI: 1.38, 2.91, p &lt; 0.001) as independent risk factors for adverse outcome. Meanwhile, optimal surgery is found to be a protective factor (HR 0.60; 95% CI: 0.41, 0.89, p = 0.011). Patients with optimal surgery had reduced the risk of adverse outcome.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Our findings confirmed that the median OS was significantly longer for patients with EOC in HA compared to IKN. However, there was no significant difference in the median OS based on the disease staging; therefore, we could not establish the non-inferiority outcome between the two centres. Furthermore, there was no significant difference in median PFS for both centres. This could be due to small sample size to be able to detect any difference. In addition, it could also be contributed by the different treatment options available and unequal volume of patients treated in both centres. Thus, further study with larger sample size and longer time period is needed to provide better guidance and treatm","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"547-555"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the relationship between the frequency of attention deficit, hyperactivity disorder symptoms and nutritional habits in children. 评估儿童出现注意力缺陷、多动障碍症状的频率与营养习惯之间的关系。
Q3 Medicine Pub Date : 2024-09-01
Ö D Elvin, Ç V Aydan, E Ç Güzel, B Topçu
<p><strong>Introduction: </strong>Attention deficit and hyperactivity disorder (ADHD) is a common chronic neurodevelopment disorder characterised by inattention, hyperactivity and impulsivity at levels that are not compatible with age. ADHD is one of the high social and individual costs for the population of the country. In the present study, it was aimed to investigate the relationship between some sociodemographic characteristics, nutrition and sleep patterns, certain habits and various factors with ADHD in primary school children aged between 6 to 10 years.</p><p><strong>Materials and methods: </strong>In the study, a total of 600 children's parents were asked to fill in the Conners Parent Rating Scale - Short Form (CPRS-48), which consists of 48 questions. The questions in the scale are answered by the parents on a four-point Likert scale. The responses were scored as 0, 1, 2 and 3 for 'never', 'rarely', 'often' and 'always', respectively. It was accepted that the children who scored at least 18 for the behaviour problem subscale, at least five for the learning problem subscale, at least six for the aggression, hyperactivity subscale, and at least seven for the defying subscale were considered to be in the problematic category. In order to determine the eating habits of the children included in the study, their parents filled out the food consumption frequency form. Foods in the form of food consumption frequency are divided into two groups as healthy and unhealthy foods. Individuals were given scores between 0 and 6 according to the frequency of food consumption. The healthy food group and unhealthy food group scores were collected separately.</p><p><strong>Results: </strong>Of the children included in the study, 312 (52%) were male, with a mean age of 8.24±1.30 (range: 6 10) years. The mean CPRS-48 score was 23.88±19.71. The Cronbach's Alpha value of the CPRS-48 scale, which consists of 48 questions in total, was obtained as 0.957. The mean CPRS-48 score was significantly higher in boys (p = 0.014), in those whose mothers smoked during pregnancy (p = 0.008), those who did not receive breast feeding at birth or those who received less than 2 months (p = 0.035), those who frequently skipped meals (p < 0.001), those who do not have breakfast regularly (p = 0.002), those who spend more than four hours a day using a tablet/computer (p = 0.007), those who watch television more than 2 hours a day (p = 0.003), those who do not have regular sleep (p = 0.012), those who sleep less than 8t hours a night (p = 0.031), those who do not spend quality time with their families at least 2 days a week (p = 0.002) and those who do not have a hobby or sport that they were constantly interested in (p = 0.007).</p><p><strong>Conclusion: </strong>The finding of the present study show that CPRS score in children is associated with some factors such as mother's habits in pregnancy, behaviours in having meals, daily habits and regular sleep. Although eating habits ar
简介注意力缺陷和多动症(ADHD)是一种常见的慢性神经发育障碍,其特征是注意力不集中、多动和冲动,其程度与年龄不符。多动症对我国人口造成的社会和个人代价都很高。本研究旨在调查 6 至 10 岁小学生的一些社会人口特征、营养和睡眠模式、某些习惯和各种因素与多动症之间的关系:研究共要求 600 名儿童的家长填写康纳斯家长评定量表-简表(CPRS-48),该量表由 48 个问题组成。该量表中的问题由家长按李克特四级量表回答。对 "从不"、"很少"、"经常 "和 "总是 "的回答分别记为 0、1、2 和 3 分。如果儿童在行为问题分量表中至少得到 18 分,在学习问题分量表中至少得到 5 分,在攻击、多动分量表中至少得到 6 分,在违抗分量表中至少得到 7 分,则被视为有问题儿童。为了确定参与研究的儿童的饮食习惯,他们的父母填写了食物消费频率表。食物消费频率表中的食物分为健康食物和不健康食物两组。根据食物消费频率,每个人的得分介于 0 到 6 之间。健康食物组和不健康食物组的分数分别收集:在参与研究的儿童中,312 名(52%)为男性,平均年龄为(8.24±1.30)岁(范围:6-10 岁)。CPRS-48 的平均得分为(23.88±19.71)分。CPRS-48 量表共有 48 个问题,其 Cronbach's Alpha 值为 0.957。男孩(P = 0.014)、母亲在怀孕期间吸烟者(P = 0.008)、出生时未接受母乳喂养或接受母乳喂养不足 2 个月者(P = 0.035)、经常不吃饭者(P < 0.001)、不定时吃早餐者(P = 0.002)、每天使用平板电脑/电脑时间超过 4 小时者(P = 0.007)、每天看电视超过 2 小时者(p = 0.003)、睡眠不规律者(p = 0.012)、每晚睡眠不足 8t 小时者(p = 0.031)、每周至少 2 天没有与家人共度美好时光者(p = 0.002)和没有自己经常感兴趣的爱好或运动者(p = 0.007):本研究结果表明,儿童的 CPRS 得分与母亲的孕期习惯、进餐行为、日常习惯和规律睡眠等因素有关。虽然饮食习惯是多动症的一个风险因素,但如果养成正确的饮食习惯,就能降低多动症的风险或症状。不过,要更好地解释这个问题,还需要进行更广泛和有效的研究。
{"title":"Evaluation of the relationship between the frequency of attention deficit, hyperactivity disorder symptoms and nutritional habits in children.","authors":"Ö D Elvin, Ç V Aydan, E Ç Güzel, B Topçu","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Attention deficit and hyperactivity disorder (ADHD) is a common chronic neurodevelopment disorder characterised by inattention, hyperactivity and impulsivity at levels that are not compatible with age. ADHD is one of the high social and individual costs for the population of the country. In the present study, it was aimed to investigate the relationship between some sociodemographic characteristics, nutrition and sleep patterns, certain habits and various factors with ADHD in primary school children aged between 6 to 10 years.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;In the study, a total of 600 children's parents were asked to fill in the Conners Parent Rating Scale - Short Form (CPRS-48), which consists of 48 questions. The questions in the scale are answered by the parents on a four-point Likert scale. The responses were scored as 0, 1, 2 and 3 for 'never', 'rarely', 'often' and 'always', respectively. It was accepted that the children who scored at least 18 for the behaviour problem subscale, at least five for the learning problem subscale, at least six for the aggression, hyperactivity subscale, and at least seven for the defying subscale were considered to be in the problematic category. In order to determine the eating habits of the children included in the study, their parents filled out the food consumption frequency form. Foods in the form of food consumption frequency are divided into two groups as healthy and unhealthy foods. Individuals were given scores between 0 and 6 according to the frequency of food consumption. The healthy food group and unhealthy food group scores were collected separately.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of the children included in the study, 312 (52%) were male, with a mean age of 8.24±1.30 (range: 6 10) years. The mean CPRS-48 score was 23.88±19.71. The Cronbach's Alpha value of the CPRS-48 scale, which consists of 48 questions in total, was obtained as 0.957. The mean CPRS-48 score was significantly higher in boys (p = 0.014), in those whose mothers smoked during pregnancy (p = 0.008), those who did not receive breast feeding at birth or those who received less than 2 months (p = 0.035), those who frequently skipped meals (p &lt; 0.001), those who do not have breakfast regularly (p = 0.002), those who spend more than four hours a day using a tablet/computer (p = 0.007), those who watch television more than 2 hours a day (p = 0.003), those who do not have regular sleep (p = 0.012), those who sleep less than 8t hours a night (p = 0.031), those who do not spend quality time with their families at least 2 days a week (p = 0.002) and those who do not have a hobby or sport that they were constantly interested in (p = 0.007).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The finding of the present study show that CPRS score in children is associated with some factors such as mother's habits in pregnancy, behaviours in having meals, daily habits and regular sleep. Although eating habits ar","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"538-546"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Halal pharmaceuticals: Views from outpatients in a Malaysian state hospital. 了解清真药品:马来西亚一家国立医院门诊患者的观点。
Q3 Medicine Pub Date : 2024-09-01
W C Ang, N A Khadir, N A S Lahazir, A H Baharudin

Introduction: Halal pharmaceuticals are paramount in healthcare settings catering to Muslim patients. The COVID- 19 pandemic ignited discussions on the Halal status of pharmaceuticals, especially vaccines. This study aims to explore the understanding and views of hospital outpatients regarding Halal pharmaceuticals.

Materials and methods: A qualitative study by in-depth interviews was undertaken among adult Muslim outpatients. Utilising a semi-structured interview guide in Malay, content reliability of the guide was ensured through expert reviews. Potential participants were approached in the outpatient pharmacy waiting area. All interviews were audio recorded and transcribed verbatim. These Malay transcripts were translated into English and subjected to thematic content analysis.

Results: Data saturation was achieved through interviewing ten outpatients. The findings indicated that patients were vigilant in checking labels to confirm the correctness of their medications. Yet, the terms 'Halal pharmaceuticals' and 'Shariah-compliant hospital' were unfamiliar to all and did not evoke curiosity. The respondents expressed trust in the government's commitment to dispense safe and Halalcertified drugs. The majority of the participants did not consider Halal status as a primary factor when selecting medications. Nevertheless given a choice, many voiced a preference for Halal-certified drugs, irrespective of their cost or efficacy. For life-threatening situations, participants were willing to accept non-Halal treatments.

Conclusion: Despite non-familiarity, the general sentiment towards Halal pharmaceuticals remain positive. This study underscores the need for enhanced education and awareness regarding Halal pharmaceuticals for better align healthcare practices with the cultural and religious values of Muslim patients.

导言:在为穆斯林患者提供服务的医疗机构中,清真药品至关重要。COVID- 19大流行引发了关于药品,尤其是疫苗的清真状态的讨论。本研究旨在探讨医院门诊患者对清真药品的理解和看法:对成年穆斯林门诊患者进行了深入访谈的定性研究。采用马来语半结构式访谈指南,通过专家评审确保指南内容的可靠性。在门诊药房等候区与潜在参与者进行了接触。所有访谈都进行了录音和逐字记录。这些马来语誊本被翻译成英语,并进行了主题内容分析:通过对 10 名门诊患者的访谈,数据达到了饱和。调查结果表明,患者在检查标签以确认药物的正确性时非常谨慎。然而,"清真药品 "和 "符合伊斯兰教法的医院 "这两个词对所有人来说都是陌生的,没有引起他们的好奇心。受访者表示相信政府承诺提供安全和符合清真标准的药品。大多数受访者在选择药物时并不将清真认证作为首要因素。然而,如果可以选择,许多人表示更愿意选择通过清真认证的药物,无论其成本或疗效如何。在危及生命的情况下,参与者愿意接受非清真治疗:结论:尽管人们对清真药品并不熟悉,但普遍对清真药品持积极态度。这项研究强调了加强有关清真药品的教育和宣传的必要性,以便更好地使医疗实践与穆斯林患者的文化和宗教价值观保持一致。
{"title":"Understanding Halal pharmaceuticals: Views from outpatients in a Malaysian state hospital.","authors":"W C Ang, N A Khadir, N A S Lahazir, A H Baharudin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Halal pharmaceuticals are paramount in healthcare settings catering to Muslim patients. The COVID- 19 pandemic ignited discussions on the Halal status of pharmaceuticals, especially vaccines. This study aims to explore the understanding and views of hospital outpatients regarding Halal pharmaceuticals.</p><p><strong>Materials and methods: </strong>A qualitative study by in-depth interviews was undertaken among adult Muslim outpatients. Utilising a semi-structured interview guide in Malay, content reliability of the guide was ensured through expert reviews. Potential participants were approached in the outpatient pharmacy waiting area. All interviews were audio recorded and transcribed verbatim. These Malay transcripts were translated into English and subjected to thematic content analysis.</p><p><strong>Results: </strong>Data saturation was achieved through interviewing ten outpatients. The findings indicated that patients were vigilant in checking labels to confirm the correctness of their medications. Yet, the terms 'Halal pharmaceuticals' and 'Shariah-compliant hospital' were unfamiliar to all and did not evoke curiosity. The respondents expressed trust in the government's commitment to dispense safe and Halalcertified drugs. The majority of the participants did not consider Halal status as a primary factor when selecting medications. Nevertheless given a choice, many voiced a preference for Halal-certified drugs, irrespective of their cost or efficacy. For life-threatening situations, participants were willing to accept non-Halal treatments.</p><p><strong>Conclusion: </strong>Despite non-familiarity, the general sentiment towards Halal pharmaceuticals remain positive. This study underscores the need for enhanced education and awareness regarding Halal pharmaceuticals for better align healthcare practices with the cultural and religious values of Muslim patients.</p>","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"512-516"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142356006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, attitude and practices of indigenous people towards non-communicable disease in Bera, Malaysia: A community-based study. 马来西亚贝拉原住民对非传染性疾病的认识、态度和做法:一项基于社区的研究。
Q3 Medicine Pub Date : 2024-09-01
F Abdullah, N A A Rahman, V Kumaran, N Fazam, C E Wong

Introduction: With the current trend of increasing noncommunicable diseases (NCD), like hypertension, diabetes and dyslipidaemia worldwide and in Malaysia, a comprehensive study is essential to find the local population's knowledge, attitude and practice towards NCD. Little is known about the indigenous people of Orang Asli's health conditions and health-seeking behaviours towards these chronic diseases. The study aimed to assess knowledge, attitudes and practices (KAP) status towards non-communicable disease and its association with demographic background among Orang Asli adults of the Semelai subgroup in central Pahang, Malaysia.

Materials and methods: A cross-sectional study was conducted among 251 adult Semelai people in Bera district, Pahang. Data was collected through face-to-face interviews to obtain socio-demographic data, KAP towards NCD. Bivariate analysis was performed to test the association between the socio-demographic factor and the KAP score.

Results: Among respondents, 57.4% were female, 82.5% were married, and 46.2% completed primary school. The majority were animism believers (83.3%), self-employed (75.3%) and earning less than RM1000 (87.6%). The respondents' ages ranged from 18 to 77, with a mean age of 41.1 (S.D ± 13.9). The prevalence of known type-2 diabetes mellitus (T2DM), hypertension, and dyslipidaemia was 9.6%, 20.7%, and 8.8%, respectively. About 23.1% of respondents have a family history of chronic disease. Regarding KAP parameters, only 12.7% have good knowledge, and 35.5% have good practice in prevention and treatment. However, more than half (59.8%) have a positive attitude towards chronic diseases. This study also showed that higher household income and education levels were positively associated with higher scores of KAP (p < 0.001).

Conclusion: This study presented a low-to-moderate percentage of Orang Asli who have good KAP towards NCD. KAP levels were significantly associated with education levels and household income. Hence, improving education and poverty in the Orang Asli community may successively increase the knowledge level, impart a positive attitude towards NCDs, and improve the practice level toward treatment and prevention.

导言:目前,全球和马来西亚的高血压、糖尿病和血脂异常等非传染性疾病(NCD)呈上升趋势,因此,有必要开展一项全面研究,以了解当地居民对 NCD 的认识、态度和做法。人们对原住民奥朗阿斯利人的健康状况和对这些慢性疾病的求医行为知之甚少。本研究旨在评估马来西亚彭亨州中部森美来亚群的原住民成年人对非传染性疾病的知识、态度和做法(KAP)状况及其与人口背景的关系:对彭亨州贝拉县的 251 名成年思美来人进行了横断面研究。通过面对面访谈收集数据,以了解社会人口学数据和对非传染性疾病的 KAP。通过双变量分析来检验社会人口学因素与 KAP 分数之间的关联:在受访者中,57.4% 为女性,82.5% 已婚,46.2% 完成小学教育。大多数受访者是泛灵论信徒(83.3%),自营职业者(75.3%),收入低于 1000 马币(87.6%)。受访者的年龄从 18 岁到 77 岁不等,平均年龄为 41.1 岁(S.D ± 13.9)。已知的 2 型糖尿病(T2DM)、高血压和血脂异常的患病率分别为 9.6%、20.7% 和 8.8%。约 23.1%的受访者有慢性病家族史。在 KAP 参数方面,只有 12.7% 的受访者在预防和治疗方面有良好的知识,35.5% 的受访者在预防和治疗方面有良好的实践。然而,超过半数(59.8%)的受访者对慢性病持积极态度。本研究还显示,较高的家庭收入和教育水平与较高的 KAP 分数呈正相关(P < 0.001):本研究表明,对非传染性疾病持有良好 KAP 的原住民比例较低。KAP 水平与教育水平和家庭收入密切相关。因此,改善orang Asli 社区的教育和贫困状况可以提高他们的知识水平,让他们对非传染性疾病持积极态度,并改善治疗和预防的实践水平。
{"title":"Knowledge, attitude and practices of indigenous people towards non-communicable disease in Bera, Malaysia: A community-based study.","authors":"F Abdullah, N A A Rahman, V Kumaran, N Fazam, C E Wong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>With the current trend of increasing noncommunicable diseases (NCD), like hypertension, diabetes and dyslipidaemia worldwide and in Malaysia, a comprehensive study is essential to find the local population's knowledge, attitude and practice towards NCD. Little is known about the indigenous people of Orang Asli's health conditions and health-seeking behaviours towards these chronic diseases. The study aimed to assess knowledge, attitudes and practices (KAP) status towards non-communicable disease and its association with demographic background among Orang Asli adults of the Semelai subgroup in central Pahang, Malaysia.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted among 251 adult Semelai people in Bera district, Pahang. Data was collected through face-to-face interviews to obtain socio-demographic data, KAP towards NCD. Bivariate analysis was performed to test the association between the socio-demographic factor and the KAP score.</p><p><strong>Results: </strong>Among respondents, 57.4% were female, 82.5% were married, and 46.2% completed primary school. The majority were animism believers (83.3%), self-employed (75.3%) and earning less than RM1000 (87.6%). The respondents' ages ranged from 18 to 77, with a mean age of 41.1 (S.D ± 13.9). The prevalence of known type-2 diabetes mellitus (T2DM), hypertension, and dyslipidaemia was 9.6%, 20.7%, and 8.8%, respectively. About 23.1% of respondents have a family history of chronic disease. Regarding KAP parameters, only 12.7% have good knowledge, and 35.5% have good practice in prevention and treatment. However, more than half (59.8%) have a positive attitude towards chronic diseases. This study also showed that higher household income and education levels were positively associated with higher scores of KAP (p < 0.001).</p><p><strong>Conclusion: </strong>This study presented a low-to-moderate percentage of Orang Asli who have good KAP towards NCD. KAP levels were significantly associated with education levels and household income. Hence, improving education and poverty in the Orang Asli community may successively increase the knowledge level, impart a positive attitude towards NCDs, and improve the practice level toward treatment and prevention.</p>","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"531-537"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractive error and amblyopia among primary school children in remote islands of East Coast of Peninsular Malaysia. 马来西亚半岛东海岸偏远岛屿小学生的屈光不正和弱视情况。
Q3 Medicine Pub Date : 2024-09-01
H J Wardati, W Karimmah, M Khadijah, M Ahmad-Sharmizi, W Y Wan-Julyatee, A S Ain-Nasyrah, M Shahidatul-Adha, H Waheeda-Azwa, K S Ng, H S Jesspreet-Kaur, N A Abdullah, H Hanizasurana, I Shatriah

Introduction: Little is known about the prevalence of refractive errors and amblyopia among school children on the islands of East Coast Malaysia. This study aimed to investigate the prevalence of these conditions and their associated factors in this unique and remote geographical location.

Materials and methods: This multicentre cross-sectional school-based study included 480 children aged 7 to 12 year from primary schools on the islands of the East Coast of Malaysia. All children underwent visual acuity assessment, orthoptic evaluation, anterior and posterior segment examinations and manifest refraction. Demographic data, history of parental refractive error, parental education level, duration of digital screen time and time spent outdoors were documented in a questionnaire distributed to the parents.

Results: The mean age was 9.53 ± 1.69 years, with an equal distribution of genders. The ethnic composition of the subjects was 99.4% Malay and 0.6% Orang Asli. The overall prevalence of refractive errors was 11.9% (95% CI: 9.1 to 15.1%), with myopia at 7.1% (95% CI: 5.0 to 9.8%), hyperopia at 2.5% (95% CI: 1.3 to 4.3%), astigmatism at 2.3% (95% CI: 1.1 to 4.1%) and amblyopia at 2.5% (95% CI: 1.3 to 4.3%). Older age, an absence of parental history of refractive error and reduced daily outdoor time were significantly associated with refractive errors (p < 0.05).

Conclusion: The prevalence of refractive error is 11.9% and amblyopia is 2.5% among primary school children on the islands of the East Coast of Peninsular Malaysia. Older age, an absence of parental history of refractive error and reduced daily outdoor time are associated with refractive error.

导言:人们对马来西亚东海岸岛屿学龄儿童屈光不正和弱视的患病率知之甚少。本研究旨在调查在这一独特的偏远地区,这些疾病的发病率及其相关因素:这项以学校为基础的多中心横断面研究包括马来西亚东海岸岛屿上小学的 480 名 7 至 12 岁儿童。所有儿童都接受了视力评估、矫形评估、前后节检查和屈光检查。向家长发放的调查问卷中记录了人口统计学数据、父母屈光不正史、父母教育水平、使用数字屏幕时间和户外活动时间:受试者的平均年龄为(9.53 ± 1.69)岁,性别分布均衡。受试者的种族构成为马来族占 99.4%,原住民占 0.6%。屈光不正的总发生率为 11.9%(95% CI:9.1% 至 15.1%),其中近视为 7.1%(95% CI:5.0% 至 9.8%),远视为 2.5%(95% CI:1.3% 至 4.3%),散光为 2.3%(95% CI:1.1% 至 4.1%),弱视为 2.5%(95% CI:1.3% 至 4.3%)。年龄较大、父母无屈光不正病史和每天户外活动时间减少与屈光不正有显著相关性(P < 0.05):马来西亚半岛东海岸岛屿上的小学生屈光不正发病率为 11.9%,弱视发病率为 2.5%。年龄较大、父母无屈光不正病史和每天户外活动时间减少与屈光不正有关。
{"title":"Refractive error and amblyopia among primary school children in remote islands of East Coast of Peninsular Malaysia.","authors":"H J Wardati, W Karimmah, M Khadijah, M Ahmad-Sharmizi, W Y Wan-Julyatee, A S Ain-Nasyrah, M Shahidatul-Adha, H Waheeda-Azwa, K S Ng, H S Jesspreet-Kaur, N A Abdullah, H Hanizasurana, I Shatriah","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Little is known about the prevalence of refractive errors and amblyopia among school children on the islands of East Coast Malaysia. This study aimed to investigate the prevalence of these conditions and their associated factors in this unique and remote geographical location.</p><p><strong>Materials and methods: </strong>This multicentre cross-sectional school-based study included 480 children aged 7 to 12 year from primary schools on the islands of the East Coast of Malaysia. All children underwent visual acuity assessment, orthoptic evaluation, anterior and posterior segment examinations and manifest refraction. Demographic data, history of parental refractive error, parental education level, duration of digital screen time and time spent outdoors were documented in a questionnaire distributed to the parents.</p><p><strong>Results: </strong>The mean age was 9.53 ± 1.69 years, with an equal distribution of genders. The ethnic composition of the subjects was 99.4% Malay and 0.6% Orang Asli. The overall prevalence of refractive errors was 11.9% (95% CI: 9.1 to 15.1%), with myopia at 7.1% (95% CI: 5.0 to 9.8%), hyperopia at 2.5% (95% CI: 1.3 to 4.3%), astigmatism at 2.3% (95% CI: 1.1 to 4.1%) and amblyopia at 2.5% (95% CI: 1.3 to 4.3%). Older age, an absence of parental history of refractive error and reduced daily outdoor time were significantly associated with refractive errors (p < 0.05).</p><p><strong>Conclusion: </strong>The prevalence of refractive error is 11.9% and amblyopia is 2.5% among primary school children on the islands of the East Coast of Peninsular Malaysia. Older age, an absence of parental history of refractive error and reduced daily outdoor time are associated with refractive error.</p>","PeriodicalId":39388,"journal":{"name":"Medical Journal of Malaysia","volume":"79 5","pages":"499-506"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142356002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Journal of Malaysia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1